[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revvity Inc (RVTY)

Revvity Inc (RVTY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Revvity Stock Underperforming the Nasdaq?

Revvity, Inc. (RVTY), headquartered in Waltham, Massachusetts, is a leading provider of health sciences solutions, technologies, and diagnostic services. Valued at $11.2 billion by market cap, the company focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and other areas.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and RVTY perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the diagnostics & research industry. Revvity’s strengths include diversification, scale, cross-business synergies, brand equity, financial resilience, and technological capabilities. These strengths enable the company to...

Fundamentals

See More
  • Market Capitalization, $K 11,155,999
  • Shares Outstanding, K 111,560
  • Annual Sales, $ 2,856 M
  • Annual Income, $ 241,200 K
  • EBIT $ 360 M
  • EBITDA $ 770 M
  • 60-Month Beta 1.11
  • Price/Sales 3.82
  • Price/Cash Flow 11.10
  • Price/Book 1.52

Options Overview Details

View History
  • Implied Volatility 43.70% (+1.86%)
  • Historical Volatility 36.08%
  • IV Percentile 71%
  • IV Rank 41.83%
  • IV High 63.49% on 10/20/25
  • IV Low 29.48% on 07/01/25
  • Expected Move (DTE 28) 3.57 (3.57%)
  • Put/Call Vol Ratio 0.73
  • Today's Volume 38
  • Volume Avg (30-Day) 32
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 2,017
  • Open Int (30-Day) 1,962
  • Expected Range 96.43 to 103.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.23
  • Number of Estimates 4
  • High Estimate $1.23
  • Low Estimate $1.21
  • Prior Year $1.18
  • Growth Rate Est. (year over year) +4.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.97 +7.56%
on 05/21/26
106.21 -5.84%
on 06/10/26
+4.52 (+4.73%)
since 05/18/26
3-Month
81.22 +23.12%
on 04/29/26
106.21 -5.84%
on 06/10/26
+15.07 (+17.74%)
since 03/18/26
52-Week
81.22 +23.12%
on 04/29/26
118.30 -15.47%
on 01/22/26
+5.59 (+5.92%)
since 06/18/25

Most Recent Stories

More News
Is Revvity Stock Underperforming the Nasdaq?

Revvity has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

$NASX : 26,517.93 (unch)
RVTY : 100.00 (+2.23%)
DHR : 177.17 (-0.33%)
2 Profitable Stocks with Impressive Fundamentals and 1 We Turn Down

2 Profitable Stocks with Impressive Fundamentals and 1 We Turn Down

TPL : 355.11 (+0.18%)
FOUR : 39.40 (+0.59%)
RVTY : 100.00 (+2.23%)
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers

Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers

RVTY : 100.00 (+2.23%)
Is Danaher Stock Underperforming the S&P 500?

Danaher has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 7,500.58 (unch)
DHR : 177.17 (-0.33%)
RVTY : 100.00 (+2.23%)
Revvity Stock: Analyst Estimates & Ratings

Revvity has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

XLV : 149.40 (-0.87%)
BCS : 26.31 (-0.08%)
$SPX : 7,500.58 (unch)
RVTY : 100.00 (+2.23%)
The Top 5 Analyst Questions From Revvity’s Q1 Earnings Call

The Top 5 Analyst Questions From Revvity’s Q1 Earnings Call

RVTY : 100.00 (+2.23%)
3 Cash-Producing Stocks That Concern Us

3 Cash-Producing Stocks That Concern Us

RHI : 31.59 (-2.08%)
CHWY : 18.21 (+2.48%)
RVTY : 100.00 (+2.23%)
RVTY Q1 2026 Deep Dive: Portfolio Pruning and AI Investments Shape Outlook

RVTY Q1 2026 Deep Dive: Portfolio Pruning and AI Investments Shape Outlook

RVTY : 100.00 (+2.23%)
S&P 500 and Nasdaq 100 Post Record Highs on Tech Strength

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.81%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.31%. June E-mini...

ALK : 49.26 (+2.05%)
DD : 47.71 (-0.50%)
AMAT : 617.11 (+4.08%)
UAL : 118.32 (+2.15%)
SNDK : 2,184.75 (+11.54%)
FISV : 47.86 (-1.87%)
ADM : 75.10 (-1.83%)
WAT : 355.44 (-0.44%)
$IUXX : 30,406.19 (unch)
DUOL : 125.56 (+1.76%)
ASML : 1,929.68 (+3.31%)
ZNU26 : 109-105 (-0.27%)
Why Is Revvity (RVTY) Stock Rocketing Higher Today

Why Is Revvity (RVTY) Stock Rocketing Higher Today

RVTY : 100.00 (+2.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software,...

See More

Key Turning Points

3rd Resistance Point 103.99
2nd Resistance Point 102.36
1st Resistance Point 101.18
Last Price 100.00
1st Support Level 98.37
2nd Support Level 96.74
3rd Support Level 95.56

See More

52-Week High 118.30
Fibonacci 61.8% 104.14
Last Price 100.00
Fibonacci 50% 99.76
Fibonacci 38.2% 95.38
52-Week Low 81.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.